Marc C. Hochberg, MD, MPH
Professor of Medicine and Epidemiology and Public Health
Chief, Division of Rheumatology and Clinical Immunology
University of Maryland School of Medicine
1.0 credit hour
NOTE: This activity was presented on March 16, 2012, in conjunction with Women's Health 2012: The 20th Annual Congress. Participants who received credit for attending the live presentation on that date are not eligible to receive credit for this online release.
Rheumatoid arthritis (RA) is a chronic inflammatory disease that is on the rise in women, who are already 3 times more likely than men to develop this potentially debilitating disease. Without appropriate treatment, RA progresses, causes joint destruction, and erodes physical function and quality of life. Therefore, early recognition and treatment initiation are critical to improving patient outcomes. The goal of this activity is to advance clinicians’ understanding of cutting-edge evidence regarding diagnosis and treatment of RA in women. Program Developer/Facilitator
This activity is jointly provided by Global Education Group and MCM Education
The educational design of this activity addresses the needs of physicians, nurse practitioners, nurses, public health professionals, and other allied healthcare providers involved in the treatment of women with rheumatoid arthritis.
Upon completion of this educational activity, the participant should be able to:
Apply the new classification criteria for RA to establish earlier disease diagnosis.
Summarize the current evidence-based guideline recommendations regarding use of nonbiologic and biologic disease-modifying antirheumatic drugs (DMARDs).
Develop a treatment plan based on the most current evidence for women with early RA to suppress ongoing inflammation and prevent joint injury.
Outline strategies to hasten initial referral and improve ongoing collaboration with rheumatologists when providing care for patients with RA.
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Hochberg, Marc C. Consulting: Abbott Laboratories, Amgen, Astra-Zeneca Pharmaceutical Co., Bristol Myers Squibb, CORRONA, Genentech/Roche, Merck & Co. Inc., NicOx S.A., Novartis Pharma AG, Pfizer Inc., Pozen Inc., Theralogix LLC, UCB Inc.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Klein, Wendy S. (VCU). Nothing to disclose
Forney, Barbara (University of Cincinnati). Nothing to disclose
Glazar, Amanda (Global). Nothing to disclose
Paczolt, Beth (MCM). Nothing to disclose
Jacobson, Anne (MCM). Nothing to disclose
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. ™
This educational activity for 1.0 contact hour is provided by Global Education Group.
Global Education Group is an approved provider of continuing nursing education by the American Nurses Credentialing Center’s COA. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Education Group is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 11021. This program has been approved for 1.0 contact hours of continuing education (which includes 0.5 hours of pharmacology).
Credit is awarded to participants who listen to the presentation and provide the requested roster information. There is no fee to participate and receive credit. For more information about the accreditation of this program, please contact Global at firstname.lastname@example.org or 303-395-1782.
Commercial Support Statements
This activity is supported by an educational donation provided by Amgen.
This activity is supported by educational grants from Abbott and Bristol-Myers Squibb.
Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7. Or, Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
Please turn off all pop-up blockers to assure access to the educational activity.
Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
The activity will take approximately 60 minutes to complete.
After the activity has finished, click on the "Post-test" button.
In order to receive credit for this activity, the participant must read the front matter, complete the pre-test, listen to the entire activity, complete the post test, scoring an 80% or higher and evaluation and apply for credit. Certificates of credit will auto-populate based on successful completion of these steps.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.